FDA Inspection 956322 — CKD Bio Corporation

CKD Bio Corporation — FEI 3002806679

The FDA completed an inspection of CKD Bio Corporation on Dec 17, 2015 in Ansan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 17, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ansan (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.